• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-60-100-120-P6
Medical Device Problem Codes Improper or Incorrect Procedure or Method (2017); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 12/28/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.After further product label review, the supera stent was implanted 3 months after the expiration date.The expiration date of the product is important for the sterility, efficacy, and performance of the device.It should be noted that the supera instruction for use (ifu) states: use this device prior to the ¿use by¿ (expiration) date as specified on the device package label.The investigation determined the reported complaint was use related.Based on the information reviewed, there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion a lesion located in the right popliteal artery that was moderately tortuous and 100% occluded prior to the intervention.A supera stent was implanted at the lesion.After stent implantation, it was noted that the stent was expired.There was no adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
See h11h6: medical device problem code 2993 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Common Device Name
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11172572
Report Number2024168-2021-00454
Device Sequence Number11671954
Product Code NIP
UDI-Device Identifier08717648211829
UDI-Public08717648211829
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
P120020
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 03/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2020
Device Model NumberS-60-100-120-P6
Device Catalogue NumberS-60-100-120-P6
Device Lot Number8100861
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 12/29/2020
Supplement Date Received by Manufacturer03/03/2021
Initial Report FDA Received Date01/14/2021
Supplement Report FDA Received Date03/07/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age60 YR
Patient Weight57
-
-